Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Peng Zhao
Institutions:
Henan University of Chinese Medicine,
First Affiliated Hospital of Henan University of Traditional Chinese Medicine
Observed institutions:
Henan University of Chinese Medicine,
First Affiliated Hospital of Henan University of Traditional Chinese Medicine,
Eternity Bioscience (United States)
ORCID:
0000-0003-1536-9575
Observed ORCID:
0000-0003-1536-9575
OpenAlex ID:
A5050239596
Discovery of spiro amide SHR902275: A potent, selective, and efficacious RAF inhibitor targeting RAS mutant cancers
2021
·
Peng Zhao
, Linghang Zhuang
, et al.
·
European Journal of Medicinal Chemistry
·
16
Discovery of Isoindoline Amide Derivatives as Potent and Orally Bioavailable ADAMTS-4/5 Inhibitors for the Treatment of Osteoarthritis
2022
·
Peng Zhao
, Dong Liu
, et al.
·
ACS Pharmacology & Translational Science
·
8
Discovery of novel spiro compound as RAF kinase inhibitor with in vitro potency against KRAS mutant cancer
2022
·
Peng Zhao
, Xiangzhu Wang
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
5
[Yiqi Zishen Formula ameliorates inflammation in mice with chronic obstructive pulmonary disease by inhibiting the PI3K/Akt/NF-κB signaling pathway].
2025
·
Liming Wang
, Hongrui Chen
, et al.
·
PubMed
·
3
Show more works
View as search
Works count:
4
Citation count:
32
H-index:
3
I10-index:
1
Year
Topic
Type